Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Byrna Technologies Inc (BYRN) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Byrna Technologies IncTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Byrna Technologies Inc vs Neurocrine Biosciences Inc — how do they compare? Byrna Technologies Inc trades at $4.35 (market cap $106.74M), while Neurocrine Biosciences Inc trades at $158.1 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 154.2× Byrna Technologies Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Byrna Technologies Inc nearer its low. Which is the better fit depends on your goals.

BYRNNBIX
Market Cap
$106.74M$16.46B
Sector
TechnologyHealth
52-Week High
$27.63$185.50
52-Week Low
$3.18$123.10
Enterprise Value
$98.35M$16.48B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Byrna Technologies Inc

Byrna Technologies specializes in less-lethal personal security devices. It develops and manufactures innovative handheld launchers and projectiles designed for self-defense, law enforcement, and private security use.

Read more on BYRN

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX